Ilona Krol

Ilona Krol

Auto-generated profile, based on publicly available information

Ilona Krol

Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2026 in Cancer Discovery
Verified
Journal Article
Open access
MSMagdalena K. Sznurkowska
Magdalena K. Sznurkowska
FCFrancesc Castro-Giner
Francesc Castro-Giner
IDIrene D’ANna
Irene D’ANna
IKIlona Krol
Ilona Krol
YZYongzhan Zhang
Yongzhan Zhang
NANicola Aceto
Nicola Aceto
Breast cancer progression to visceral organs such as the lung and liver is associated with poor prognosis. However, these organs have diverse cellular microenvironments that may differentially influence cancer cell behavior. In this study, we show that breast cancer metastases differ in their capacity for secondary seeding: the liver fosters metastasis-promoting properties and boosts secondary spread, whereas the lung restricts these processes, favoring local growth. Using patient data and rapid autopsy tissues, mouse models with barcode-mediated tracing, niche-labeling technology, and single-cell analysis of tumor cells and their direct microenvironment, we dissect the cellular and molecular microenvironmental factors underlying this differential behavior. Mechanistically, we identify BMP2-producing endothelial cells as critical players within the liver metastatic niche, enhancing metastasis-to-metastasis dissemination. Targeting the BMP2 signaling axis suppresses the secondary spread of liver-derived breast cancer lesions. Altogether, we reveal site-specific behavior of lung and liver metastases in breast cancer, highlighting microenvironmental mechanisms and therapeutic opportunities for intervention. Significance: This study establishes that metastatic organs differentially regulate subsequent breast cancer dissemination, with the liver promoting and the lung restraining secondary spread. We identify endothelial BMP2 as a liver niche signal that metabolically primes breast cancer cells for further metastasis, revealing a therapeutic target to curb secondary spread.